Stein Robert Benjamin's Form 4 filing
Mimedx Group, Inc. (MDXG) · filed Sep 14, 2022
- Accession no.
- 0001376339-22-000114
- Filed
- Sep 14, 2022
- Trade date
- Sep 12-13, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $94.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stein Robert BenjaminCIK 0001597158 | Officer (President, Regenerative Med.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2022 | Common Stock | SSaleDisposed | −19,000 | $3.44 | −$65,360 | 287,002 | Direct | |
| Sep 13, 2022 | Common Stock | SSaleDisposed | −8,329 | $3.46 | −$28,818.34 | 278,673 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.